FDA Inspection 1022108 — Phoenix Diagnostics, Inc.

Phoenix Diagnostics, Inc. — FEI 1222035

The FDA completed an inspection of Phoenix Diagnostics, Inc. on Aug 18, 2017 in Natick, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). 6 citations were issued during this inspection. Product area: Devices.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Aug 18, 2017
Fiscal Year
2017
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Natick, MA (United States)

Citations

IDCFRDescription
235021 CFR 820.25(b)Training - Lack of or inadequate procedures
313021 CFR 820.100(a)Lack of or inadequate procedures
313221 CFR 820.120Lack of or inadequate procedures for labeling
326221 CFR 820.250(a)Statistical techniques - Lack of or inadequate procedures
53721 CFR 820.70(a)Production processes
54621 CFR 820.75(a)Lack of or inadequate process validation

Need the full FDA record for Phoenix Diagnostics, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.